Nicole Goh is a Respiratory Physician with an interest in interstitial lung disease. She is the Director of ILD services at the Austin Hospital in Melbourne and is actively involved with the Centre of Research Excellence in Pulmonary Fibrosis.

Matt is a pulmonologist, genetic epidemiologist, associate director for the Center for Pulmonary Functional Imaging, and the director of the Interstitial Lung Disease Program at the Brigham and Women's Hospital. He completed medical school at the University of Iowa, residency and chief residency at Virginia Commonwealth University, and a pulmonary fellowship and a Master’s of Public Health at Harvard where he is now an Associate Professor of Medicine. In addition, to caring for patient’s in the Intensive Care Unit, and in the Interstitial Lung Disease Clinic his research has been focused on identifying the factors that will help to diagnose early stages of pulmonary fibrosis. The overarching goal of this work is to target specific groups most likely to progress to pulmonary fibrosis with the hope preventing the more advanced stages of this incurable disease. He is the Principal Investigator or co-Principal Investigator on 3 R01 grants as well as the site-PI on numerous pharmaceutical sponsored clinical trials. This work has helped to change our understanding of early stages of pulmonary fibrosis and has led to the first international guidelines for the recommendation on reporting and following patients with evidence for early stages of this disease. His grants have focused on three main themes including 1) defining the phenotype and risk factors that best help to predict early stages of pulmonary fibrosis and their progression, 2) genetic, genomic, and proteomic analyses that help to demonstrate the most important genes, and pathways associated with early pulmonary fibrosis development, and 3) screening studies to identify early-stage pulmonary fibrosis in families. Dr. Hunninghake’s ultimate goal is to consider targeted interventional efforts to reduce the progression of early stages of pulmonary fibrosis.

Dr Miranda Siemienowicz is a thoracic radiologist at Northern Health in Melbourne. She is chair of the Australian and New Zealand Society of Thoracic Radiology and is the Clinical Lead for the National Lung Cancer Screening Program (NLCSP) for the Royal Australian and New Zealand College of Radiologists. Dr Siemienowicz has an interest in interstitial lung disease and provided radiology interpretation for the 2024 international virtual ILD multidisciplinary meetings hosted by Boehringer Ingelheim (the ASEAN-Korea-ANZ ILD MDD). She sits on the Expert Advisory Committee and the Data Development Working Group for the NLCSP for the Department of Health and Aged Care and is a member of the Lung Cancer Working Party of the Thoracic Society of Australia and New Zealand. At Northern Health, she is CT Clinical Lead and Director of Training.

Professor Paul Reynolds is currently the Medical Lead/Clinical Director of the Heart and Lung Program of the Central Adelaide Local Health Network. He trained at the University of Adelaide and the Royal Adelaide Hospital in General and Thoracic Medicine. He was admitted as a Fellow of the Royal Australasian College of Physicians in 1992. He completed a PhD in airway inflammation at the Hanson Institute then spent five years working in the USA at the University of Alabama at Birmingham Division of Human Gene Therapy. In 2002 he returned to the Royal Adelaide Hospital Department of Thoracic Medicine as Senior Consultant Physician and Director of the Lung Research Laboratory, Hanson Institute. He was awarded an MD for his Gene Therapy work in 2009, which involved gene therapy strategies for pulmonary hypertension. He is a former President of the TSANZ and winner of the Society Medal. He is an active clinician and currently Chairs the CREATE Early Career development program of the CRE for Interstitial Lung Disease.

Nicole Goh is a Respiratory Physician with an interest in interstitial lung disease. She is the Director of ILD services at the Austin Hospital in Melbourne and is actively involved with the Centre of Research Excellence in Pulmonary Fibrosis.

Yet Khor is an NHMRC emerging leadership fellow at Monash University and an interstitial lung disease specialist at Austin and Alfred Health. She is the chair of TSANZ Clinical Care and Resources Sub-Committee.